The Founders of the CRC Network
After many years collaboration, several studies and multiple papers on colorectal cancer, the four Professors decided in 2016 to establish the CRC Network. Getting together, learning from acknowledged experts, discussing face to face and sharing thoughts, ideas flourish and solutions for patients suffering from Colorectal cancer are explored.Recent articles
by the founders of the CRC Network
- Germline MBD4 deficiency causes a multi-tumor predisposition syndrome pubmed:35460607
- Phenome-wide association study (PheWAS) of colorectal cancer risk SNP effects on health outcomes in UK Biobank pubmed:34912076
- The Bowel Cancer Screening Programme Expert Board: an analysis of activity during 2017-2020 pubmed:34773294
- Increased somatic mutation burdens in normal human cells due to defective DNA polymerases pubmed:34594041
- Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer pubmed:34479131
- Bidirectional Mendelian randomisation analysis of the relationship between circulating vitamin D concentration and colorectal cancer risk pubmed:34449871
- Non-Lynch Familial and Early-Onset Colorectal Cancer Explained by Accumulation of Low-Risk Genetic Variants pubmed:34359758
- Genetic mapping of novel modifiers for ApcMin induced intestinal polyps' development using the genetic architecture power of the collaborative cross mice pubmed:34294033
- Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication pubmed:34228709
- Stromal composition predicts recurrence of early rectal cancer after local excision pubmed:34174109
- The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management pubmed:33948826
- Correction to: The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability pubmed:33794988
- Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study pubmed:33510439
- The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer pubmed:33223535
- Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer pubmed:33219056
- In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer pubmed:33028592
- Current dilemmas in the pathological staging of colorectal cancer: the results of a national survey pubmed:33001486
- Young-onset colorectal cancer is associated with a personal history of type 2 diabetes pubmed:32885561
- Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer pubmed:32851660
- Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning pubmed:32690604
- Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis pubmed:32684988
- The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability pubmed:32641106
- Prediction of colorectal cancer risk based on profiling with common genetic variants pubmed:32638365